| Identification | Back Directory | [Name]
Metazosin | [CAS]
95549-92-1 | [Synonyms]
Kenosin
Vufb15111
Metazosin
(+-)-4-Amino-2-(4-(2-methoxypropionyl)piperazino)-6,7-dimethoxyquinazoline
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-methoxy-1-oxopropyl)piperazine
(+-)-1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-methoxypropionyl)piperazine
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-methoxy-1-oxopropyl)-
1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-2-methoxypropan-1-one
1-Propanone, 1-[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-methoxy- | [Molecular Formula]
C18H25N5O4 | [MDL Number]
MFCD00891638 | [MOL File]
95549-92-1.mol | [Molecular Weight]
375.42 |
| Hazard Information | Back Directory | [Uses]
Metazosin is an α-adrenergic receptor antagonist useful in the treatment of hypertension and cardiac insufficiency. It is also used in the preparation of injectable solutions containing quinazolinyl propionyl piperazine. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|